United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019 - 08/07/21
: 1st Lt., Peter Knabel, DO a, Alan B. Fleischer, MD aAbstract |
Background |
Skin cancer is the most common cancer worldwide.
Objective |
To evaluate the burden of skin cancer in the US from 1990 to 2019.
Methods |
Age-standardized incidence, prevalence, disability-adjusted life years (DALY), and mortality rates from skin cancer in the US were evaluated from the Global Burden of Disease 2019.
Results |
Incidence, prevalence, DALY, and mortality rates for melanoma per 100,000 persons in 2019 were 17.0, 138, 64.8, and 2.2, respectively; for squamous cell carcinoma, rates were 262, 314, 26.6, and 0.8, respectively; and for basal cell carcinoma, rates were 525, 51.2, 0.2, and zero, respectively. Incidence and prevalence rates of melanoma and non-melanoma skin cancer (NMSC) have increased since 1990, while mortality rates have remained fairly stable. Males have had higher incidence, prevalence, DALY, and mortality rates from melanoma and NMSC every year since 1990. Incidence and prevalence of melanoma was relatively higher in the northern half of the US than in the southern half.
Limitations |
Global Burden of Disease is derived from estimation and mathematical modeling.
Conclusions |
Health care professionals can utilize differences and trends noted in this study to guide allocation of resources to reduce incidence and morbidity from skin cancer.
Le texte complet de cet article est disponible en PDF.Key words : basal cell carcinoma, epidemiology, melanoma, public health, skin neoplasm, squamous cell carcinoma
Abbreviations used : DALY, NMSC, BCC, SCC, UI, GBD
Plan
| Funding sources: None. |
|
| IRB approval status: Not required. |
|
| Reprints not available from the authors. |
Vol 85 - N° 2
P. 388-395 - août 2021 Retour au numéro
Article précédent
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Brett King, Emma Guttman-Yassky, Elena Peeva, Anindita Banerjee, Rodney Sinclair, Ana B. Pavel, Linda Zhu, Lori Ann Cox, Brittany Craiglow, Linda Chen, Christopher Banfield, Karen Page, Weidong Zhang, Michael S. Vincent
- Psoriasis and mortality in the United States: Data from the National Health and Nutrition Examination Survey
- Yevgeniy R. Semenov, Christina M. Herbosa, Andrew T. Rogers, Amy Huang, Shawn G. Kwatra, Bernard Cohen, Milan J. Anadkat, Jonathan I. Silverberg
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?